Healthcare

Nutex Health Inc. (NASDAQ: NUTX) reported a significant drop in revenue, falling to $15 million for the second quarter, a decrease of 87% from $115 million in the same quarter last year. This substantial revenue contraction raises concerns as it comes alongside a backdrop …

This results surpassed analysts' consensus estimate of a $0.15 earnings per share (EPS), compared to expectations of a $-0.02 EPS. The strong revenue figures highlight the company's ability to capitalize on the growing demand for virtual healthcare solutions and its effective strategic initiatives. This …

OmniAb, Inc. posted second‑quarter revenue of $13.4 million, an increase from $3.9 million in the comparable period a year earlier, while its net loss narrowed to $5.9 million versus $15.9 million. The improvement was driven by milestone receipts, new ion‑channel service contracts and stronger …

Organogenesis Holdings (NASDAQ: ORGO) signed an at‑the‑market sales agreement on Aug 6, 2026 that authorizes the company to sell up to $75 million of its Class A common stock. The agreement appoints BTIG and Citizens JMP Securities as agents and sets a commission ceiling …

Organogenesis Holdings Inc. (NASDAQ: ORGO) announced second‑quarter 2026 results that showed revenue slumping 58% to $42.8 million, while the bottom line deepened into a $96.3 million loss, far exceeding the $9.4 million loss recorded a year earlier. Earnings per share came in at $‑0.71 …

Hyperfine (NASDAQ: HYPR) posted second‑quarter revenue of $3.9 million, a 44.8% jump from the same period a year earlier, while reporting a net loss of $9.3 million, or $0.09 per share, in line with consensus expectations. The company shipped 12 Swoop® portable MRI systems, …

This acquisition is part of iRhythm's strategy to enhance its competitive edge in the healthcare technology sector. Investors will watch closely, as this deal represents a significant move to diversify and improve iRhythm's existing offerings, which may set the tone for future growth.